Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Humacyte, Inc. Director's Dealing 2020

Sep 23, 2020

33410_dirs_2020-09-23_4d2c04e2-5b00-4ae5-a40d-c3e955e94b53.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Alpha Healthcare Acquisition Corp. (AHACU)
CIK: 0001818382
Period of Report: 2020-09-22

Reporting Person: Shukla Rajiv (Director, Chief Executive Officer, 10% Owner)
Reporting Person: AHAC Sponsor LLC (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-09-22 Class A Common Stock J 305000 $10 Acquired 305000 Indirect

Footnotes

F1: Consists of 305,000 placement units purchased by AHAC Sponsor LLC ("Sponsor") for $10.00 per unit in a private placement transaction with the registrant. Each such unit consists of one share of Class A common stock and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment.

F2: Sponsor is the record holder of the securities reported herein. Mr. Rajiv Shukla is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. Mr. Shukla disclaims beneficial ownership over any securities in which he does not have a pecuniary interest.